The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors
Open accessAbstract
BACKGROUND: Arthralgia is common in postmenopausal breast cancer survivors (BCS) who are receiving aromatase inhibitors (AIs). The objective of this study was to evaluate the perceived onset, characteristics, and risk factors for AI‐related arthralgia (AIA). METHODS: In a cross‐sectional survey of postmenopausal BCS who were receiving adjuvant AI therapy at a university‐based oncology clinic, patient‐reported attribution of AIs as a cause of joint pain was used as the primary outcome. Multivariate logistic regression analyses were performed to evaluate risk factors. RESULTS: Among 300 survey respondents, 139 (47%) attributed AI as a cause of their current arthralgia. Of those patients, 74% recognized the onset of AIA within 3 months of starting medication, and 67% rated joint pain as moderate or severe in the previous 7 days. In multivariate logistic regression analyses, the time since last menstrual period (LMP) was the only significant predictor of AIA. Controlling for covariates, the women who had their LMP within 5 years had the highest probability of reporting AIA (73%), whereas those who had their LMP ≥10 years previously had the lowest probability of reporting AIA (35%; adjusted odds radio, 3.39; 95% confidence interval, 1.21‐9.44; P = .02). Wrists/hands, ankles/feet, elbows, and knees appeared to be associated more strongly with AI‐related symptoms than non‐AI–related joint symptoms (all P < .01). CONCLUSIONS: AIA was common, began within the first 3 months of therapy in most patients, and appeared to be related inversely to the length of time since cessation of menstrual function. These findings suggest that estrogen withdrawal may play a role in the mechanism of this disorder. Cancer 2009. © 2009 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Crew, K. D., Capodice, J. L., Greenlee, H., Apollo, A., Jacobson, J. S., Raptis, G., Blozie, K., Sierra, A., & Hershman, D. L. (2007) · Journal of Cancer Survivorship · doi:10.1007/s11764-007-0034-x · Cited by 87
Cited by
Henry, N. L., Azzouz, F., Desta, Z., Li, L., Nguyen, A. T., Lemler, S., Hayden, J., Tarpinian, K., Yakim, E., Flockhart, D. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0261 · Cited by 383
Cancer, Physical Activity, and Exercise
Brown, J. C., Winters‐Stone, K., Lee, A., & Schmitz, K. H. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c120005 · Cited by 346
Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors
Irwin, M. L., Cartmel, B., Gross, C. P., Ercolano, E., Li, F., Yao, X., Fiellin, M., Capozza, S., Rothbard, M., Zhou, Y., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1547 · Cited by 324
Glare, P. A., Davies, P. S., Finlay, E., Gulati, A., Lemanne, D., Moryl, N., Oeffinger, K. C., Paice, J. A., Stubblefield, M. D., & Syrjala, K. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4629 · Cited by 329
Metadata
- Authors
- Mao, J. J., Stricker, C., Bruner, D., Xie, S., Bowman, M. A., Farrar, J. T., Greene, B. T., & DeMichele, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-06-10
- Volume
- 115
- Issue
- 16
- Pages
- 3631-3639
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2047996370
- Cited by
- 201
- References
- 2
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors. https://app.cochat.ai/papers/10.1002/cncr.24419
- The paper
- Mao, J. J., Stricker, C., Bruner, D., Xie, S., Bowman, M. A., Farrar, J. T., Greene, B. T., & DeMichele, A. (2009). Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors. Cancer. https://doi.org/10.1002/cncr.24419
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.